PrednisoneVincristineImmune SystemCyclophosphamideGlucocorticoidsDoxorubicinProcarbazineAntineoplastic Combined Chemotherapy ProtocolsImmunosuppressive AgentsMechlorethaminePrednisoloneAzathioprineImmune ToleranceTreatment OutcomeMelphalanDrug Therapy, CombinationAntibodies, Monoclonal, Murine-DerivedMitoxantroneAnti-Inflammatory AgentsDrug Administration ScheduleImmunity, InnateBleomycinMethotrexateColor TherapyRemission InductionLymphoma, Non-HodgkinChlorambucilT-LymphocytesCyclosporineImmune EvasionTime FactorsHodgkin DiseaseAntigen-Antibody ComplexAdministration, OralImmune SeraLymphoma, Large B-Cell, DiffuseImmunoglobulin GMycophenolic AcidImmunity, CellularGraft RejectionAdrenal Cortex HormonesFollow-Up StudiesCytokinesVinblastineMultiple MyelomaKidney TransplantationMice, Inbred C57BLImmunosuppressionAsparaginaseThalidomideLymphocyte ActivationImmunityMice, Inbred BALB CSurvival AnalysisImmune Complex DiseasesImmune System DiseasesRecurrenceAntibody FormationEtoposideAntibodies, MonoclonalTacrolimusMethylprednisoloneDisease-Free SurvivalSurvival RateSpleenCombined Modality TherapyImmunologic FactorsDendritic CellsNephrotic SyndromeInterferon-gammaClinical Trials as TopicAdaptive ImmunityCyclosporinsLymphocytes6-MercaptopurineCD4-Positive T-LymphocytesArthritis, RheumatoidPolymyalgia RheumaticaProspective StudiesPrognosisLupus Erythematosus, SystemicLymphoma, FollicularDose-Response Relationship, DrugGraft SurvivalInfectionB-LymphocytesImmune Reconstitution Inflammatory SyndromeThrombocytopeniaEtiocholanoloneDouble-Blind MethodVindesineCarmustineRetrospective StudiesDexamethasoneAndrostenolsTaxoidsCells, CulturedFlow CytometryImmunizationAutoimmune Diseases